Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome? This paper is dedicated to Sofia Maione born during COVID-19 outbreak

Research output: Contribution to journal › Letter

Authors

  • Gian Marco Casillo
  • Adel Abo Mansour
  • Federica Raucci
  • Anella Saviano
  • Nicola Mascolo
  • Francesco Maione

Colleges, School and Institutes

Details

Original languageEnglish
Article number104791
Number of pages2
JournalPharmacological Research
Volume156
Early online date14 Apr 2020
Publication statusPublished - Jun 2020
Save citation Saved citations (0)

Copy the text from this field...

View graph of relations

Documents

  • Casillo_et_al_Could_IL_17_represent_a_new_therapeutic_target_for_the_treatment_and/or_management_of_COVID-19-related_respiratory_syndrome?_Pharmacological_Research_2020

    Accepted author manuscript, 196 KB, PDF document

    Embargo ends: 14/04/21

    Licence: Creative Commons: Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) Show licence

DOI

By the same authors

The Role and Impact of Extracellular Vesicles in the Modulation and Delivery of Cytokines during Autoimmunity

Asif Jilani Iqbal, 26 Sep 2020, In : International Journal of Molecular Sciences. 21, 19

Research output: Contribution to journal › Review article

The functional link between microsomal prostaglandin E synthase-1 (mPGES-1) and peroxisome proliferator-activated receptor γ (PPARγ) in the onset of inflammation

Asif Jilani Iqbal, Jul 2020, In : Pharmacological Research. 157, 104807.

Research output: Contribution to journal › Article